Drug Identity
Active Ingredient
Metoclopramide
Chemical Class
Benzamide
Pharmacological Group
on the basis of mechanism of action and also cl...
ATC Code
A03FA01
Status
Essential Medicine
What is Metoca?
Uses
Monjuvi is used to treat diffuse large B-cell lymphoma (DLBCL ) in combination with lenalidomide that is relapsed or refractory (r/r), or...
How It Works
Chemical Class
Benzamide
Pharmacological Group
on the basis of mechanism of action and also classified in Histamine (H-2) Antagonists and GI Agent, Prokinetic pharmacological group
Metoclopramide is the derivative of Metoclopramide (HCl). It is of Synthetic origin and belongs to Benzamide. It belongs to D2 antagonist pharmacological group on the basis of mechanism of action and also classified in Histamine (H-2) Antagonists and GI Agent, Prokinetic pharmacological group. The Molecular Weight of Metoclopramide (HCl) is 299.80. Its pKa is 4.45, 9.2.
How to Take It
1
Adult · PO,IV,IM
10 to 15 mg — 6 hourly
Renal dysfunction: decrease dose.
2
Child · Intra Muscular
0.1 to 0.2 mg/kg — 8 hourly
-
3
Child · Intra Venous
0.1 to 0.2 mg/kg — 8 hourly
-
4
Child · Oral
0.1 to 0.2 mg/kg — 8 hourly
-
Safety Alerts
Before you receive Monjuvi, tell your healthcare provider about all of your medical conditions, including if you: have an active infection or have had one recently are pregnant or plan to become pregnant are breastfeeding or plan to breastfeed
Important Warnings
Monjuvi may cause the following serious side effects: Infusion reactions
Your healthcare provider will monitor you for infusion reactions during your infusion of Monjuvi
Tell your healthcare provider right away if you get a fever, chills, rash, flushing, headache, or shortness of breath during an infusion of Monjuvi
Low blood cell counts (platelets, red blood cells, and white blood cells)
Low blood cell counts are common with Monjuvi, but can also be serious or severe
Your healthcare provider will monitor your blood counts during treatment with Monjuvi
Tell your healthcare provider right away if you get a fever of 100
4°F (38°C) or above, or any bruising or bleeding, or fever, mouth sores, skin sores, sore throat , cough, trouble breathing
Side Effects
The most common side effects of Monjuvi when given with lenalidomide in DLBCL are: respiratory tract infection feeling tired or weak diarrhea cough fever swelling of the lower legs or hands decreased appetite infusion-related reactions. The most common side effects of Monjuvi when given with lenalidomide and rituximab in FL are: respiratory tract infections diarrhea rash feeling tired or weak muscle and bone pain constipation cough infusion-related reactions.
Drug Interactions
Other drugs may interact with Monjuvi
including prescription and over-the-counter medicines
vitamins
and herbal products . Tell your healthcare provider about all the medicines you take
including prescription and over-the-counter medicines
vitamins
and herbal supplements.
Storage
Inj (reconstituted soln) Store at room temperature. Use within 24 hrs if kept at room temperature. Syrup, Inj Store Below 40°C. Do not Freeze. Protect from Sunlight. Tab, Oral Soln Store in a well closed container, Below 40°C. Protect from Sunlight.
Price Intelligence
Rs 31.79
DRAP approved maximum price · per 50ml · approved 27 Jul, 2026
No retail price observed for this pack. Retailers may not exceed the approved maximum.
Prices across sources
No retail prices recorded
Should you consider an alternative?
Other options containing Metoclopramide, and what they are not.
Identical active ingredient at the same strength. Cheapest per unit first.
Vomilideoral
5mg/5ml
Rs 33.33
No DRAP alertsEPHARM LABORATORIES
Meclokyt
5mg/5ml
Rs 59.06
High-Q Pharmaceuticals
Ordered by lowest price per unit where a pack size is known, then by price. Order is never affected by sponsorship. Not medical advice — confirm any change with your pharmacist or doctor.
For pharma professionalsCompany, market and opportunity intelligence
Company
453
brands
394
molecules
2
alerts